emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Le Noble Age (LNA Santé) / Clinique Développement

No EMAT : 100887
Announced Date : 18/06/2020
Type : Exit ,Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Le Noble Age (LNA Santé)

Target : Clinique Développement
Country : Seine-Maritime
Sector of activity :
  • Health Care Providers > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Clinics and hospitals
Business Description :
Founded by Dr. Tanguy de la Bourdonnaye in 1997, Clinique Développement owns and operates medical and surgical centers . > Provides healthcare services in the areas of digestive and visceral...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Clinics and hospitals » = 118
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
12/02/2019 Private Group Led by Signet Healthcare Partners & RoundTable Healthcare Partners OTC-Business of Moberg Pharma (MPJ OTC) Sweden *** 100875
30/11/2019 Private Group led by Omnes Capital Biofutur Val-D'Oise * 100831

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report